Schmitz E, Reichelt R, Walkowiak W, Richards J G, Hebebrand J
Institut für Humangenetik, Universität Bonn, F.R.G.
Brain Res. 1988 Nov 15;473(2):314-20. doi: 10.1016/0006-8993(88)90860-8.
In mammalian cerebella the distribution of high affinity GABAA and benzodiazepine binding sites does not parallel each other. Differences in the molecular structure of the receptor complex or conformational changes have been proposed to explain the lack of a co-localization of these binding sites. Using radio- and immunohistochemistry we were able to obtain similar results for cerebella of non-mammalian species, indicating that the respective distribution of the binding sites is well conserved throughout vertebrate evolution. The gamma-aminobutyric acid agonist [3H]muscimol and the beta-subunit specific antibody bd-17 strongly labeled the granular layer. The radioligands for the benzodiazepine binding site [3H]flunitrazepam and [3H]Ro 15-1788 revealed species variation in the ratio of benzodiazepine receptor density in the granular and molecular layers. In human and pig cerebellum, the localization of antigenic sites recognized by the alpha-subunit specific antibody bd-24 deviates from the distribution of the benzodiazepine binding sites.
在哺乳动物小脑中,高亲和力γ-氨基丁酸A型(GABAA)受体和苯二氮䓬结合位点的分布并不相互平行。有人提出,受体复合物分子结构的差异或构象变化可解释这些结合位点缺乏共定位的现象。我们利用放射自显影和免疫组织化学方法,在非哺乳动物物种的小脑中获得了类似结果,表明在整个脊椎动物进化过程中,这些结合位点的各自分布情况保存完好。γ-氨基丁酸激动剂[3H]蝇蕈醇和β亚基特异性抗体bd-17强烈标记颗粒层。苯二氮䓬结合位点的放射性配体[3H]氟硝西泮和[3H]Ro 15-1788显示,颗粒层和分子层中苯二氮䓬受体密度的比值存在物种差异。在人类和猪的小脑中,α亚基特异性抗体bd-24识别的抗原位点定位与苯二氮䓬结合位点的分布不同。